Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The main objective of this study is to evaluate the feasibility of estimating the prevalence of stage 4 and 5 chronic kidney disease in the Gard department of France from data obtained via laboratory databases. To verifiy if the demand for care thus authenticated by laboratory tests is adapted to nephrology care delivery, as recommended by the French High Authority of Health (HAS), laboratory data will be compared with those of patients seen by nephrologists in the department.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| The study population | Persons with stage >=4 chronic kidney disease. |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| The prevalence of chronic kidney disease stage > = 4 in the Gard according to laboratory data (raw number) | from baseline (day 0) to 12 months | |
| The prevalence of chronic kidney disease stage > = 4 in the Gard according to laboratory data (%) | from baseline (day 0) to 12 months |
| Measure | Description | Time Frame |
|---|---|---|
| The percentage of patients with CKD stage >= 4 correctly reported by participating nephrologists | from baseline (day 0) to 12 months | |
| For each nephrologist participating in the study, the % of patients with stage >=4 chronic kidney disease who are correctly declared |
Not provided
Inclusion Criteria:
Exclusion Criteria:
-
Not provided
Not provided
Not provided
Not provided
Persons with >= stage 4 chronic kidney disease and residing in the Gard department of France.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Olivier Moranne, MD, PhD | Contact | +33.(0)4.66.68.31.49 | olivier.moranne@chu-nimes.fr |
| Name | Affiliation | Role |
|---|---|---|
| Olivier Moranne, MD, PhD | Centre Hospitalier Universitaire de Nīmes | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| AIDER - Unité de Dialyse d'Alès | Recruiting | Alès | 30100 | France |
Not provided
| ID | Term |
|---|---|
| D051436 | Renal Insufficiency, Chronic |
| ID | Term |
|---|---|
| D051437 | Renal Insufficiency |
| D007674 | Kidney Diseases |
| D014570 | Urologic Diseases |
| D052776 | Female Urogenital Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| from baseline (day 0) to 12 months |
| The % of patients with chronic kidney disease stage > = 4 in the Gard according to laboratory data and who are not seen by a nephrologist | from baseline (day 0) to 12 months |
| AIDER - Unité de Dialyse de Nîmes, CHU Carémeau | Not yet recruiting | Nîmes | 30029 | France |
|
| CHU de Nîmes - Hôpital Universitaire Carémeau | Not yet recruiting | Nîmes | 30029 | France |
|
| Gardialyse | Not yet recruiting | Nîmes | 30900 | France |
|
| D005261 |
| Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |
| D002908 | Chronic Disease |
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |